drugset / Trial / NCT04042233
Intraosseous Vancomycin in Primary Total Hip Arthroplasty - Designing a Protocol
RandomizedParallel-groupSingle-blindPrevention
Summary
The objective of this study is to evaluate a novel vancomycin intraosseous administration protocol vs a standard IV vancomycin administration protocol for primary total hip arthroplasty patients.
Timeline
- Start
- 2019-12-31
- Primary completion
- 2022-05-25
- Completion
- 2022-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vancomycin | Other / unclassified | 15 mg/kg | Intravenous |
| Subject | Vancomycin | Other / unclassified | 500 mg | Intravenous |
| Comparator | Cefepime | Small molecule | — | Intravenous |